deltatrials
Unknown PHASE3 NCT00006468

Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Phase III Study of An Optimized LV-5FU-Oxaliplatin Regimen in Metastatic Colorectal Cancer. C99-1.

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group

Conditions Colorectal Cancer
Interventions FOLFOX regimen fluorouracil leucovorin calcium oxaliplatin
Updated 6 times since 2017 Last updated: Jan 10, 2009 Started: Jan 31, 2000

This PHASE3 trial investigates Colorectal Cancer and is currently ongoing. GERCOR - Multidisciplinary Oncology Cooperative Group leads this study, which shows 6 recorded versions since 2000 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE3

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE3

  5. Feb 2018 — Jun 2018 [monthly]

    Unknown Status PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2018 [monthly]

    Unknown Status PHASE3

    First recorded

Jan 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GERCOR - Multidisciplinary Oncology Cooperative Group
Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Paris, France